INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $223,000 | +10.9% | 2,800 | +40.7% | 0.03% | -3.7% |
| Q4 2018 | $201,000 | -19.9% | 1,990 | 0.0% | 0.03% | -10.0% |
| Q3 2018 | $251,000 | -33.4% | 1,990 | -55.7% | 0.03% | -36.2% |
| Q2 2018 | $377,000 | +18.6% | 4,490 | -13.1% | 0.05% | +14.6% |
| Q1 2018 | $318,000 | +5.3% | 5,164 | 0.0% | 0.04% | +24.2% |
| Q4 2017 | $302,000 | -10.9% | 5,164 | -11.7% | 0.03% | -13.2% |
| Q3 2017 | $339,000 | -41.6% | 5,846 | +22.0% | 0.04% | -42.4% |
| Q2 2017 | $580,000 | +7.0% | 4,792 | 0.0% | 0.07% | +4.8% |
| Q1 2017 | $542,000 | +81.3% | 4,792 | +74.1% | 0.06% | +75.0% |
| Q4 2016 | $299,000 | -31.4% | 2,752 | +3.8% | 0.04% | -32.1% |
| Q3 2016 | $436,000 | +15.3% | 2,652 | 0.0% | 0.05% | +10.4% |
| Q2 2016 | $378,000 | +10.9% | 2,652 | 0.0% | 0.05% | +9.1% |
| Q1 2016 | $341,000 | -13.9% | 2,652 | 0.0% | 0.04% | -12.0% |
| Q4 2015 | $396,000 | -10.0% | 2,652 | 0.0% | 0.05% | -13.8% |
| Q3 2015 | $440,000 | -16.8% | 2,652 | +21.0% | 0.06% | -4.9% |
| Q2 2015 | $529,000 | -14.4% | 2,192 | 0.0% | 0.06% | -15.3% |
| Q1 2015 | $618,000 | +80.7% | 2,192 | 0.0% | 0.07% | +75.6% |
| Q4 2014 | $342,000 | – | 2,192 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |